# Achievement: 94% Mean F1, 92% Weighted F1

## What We Accomplished

### Starting Point (3 hours ago):
- Mean F1: **88.4%**
- Weighted F1: **87.0%**
- NCD 210.3 (Colorectal Cancer): **47% F1** 🔴 CRITICAL FAILURE

### After Improvements:
- Mean F1: **93.8%** (+5.4 points)
- Weighted F1: **91.9%** (+4.9 points)
- NCD 210.3 (Colorectal Cancer): **80% F1** (+33 points) ✅

---

## How We Got Here

### Step 1: Identified the Problem (87% weighted F1)
- Clinical safety analysis showed cancer screening at only 85.1% mean
- NCD 210.3 at 47% F1 was the critical failure
- Weighted F1 (87%) properly reflected patient harm

### Step 2: Applied Few-Shot + Multi-Pass Extraction
- **Few-shot prompting**: Added 3 examples of successful extractions
- **Multi-pass extraction**: 
  - Pass 1: Focus only on finding ALL HCPCS codes
  - Pass 2: Focus only on frequency limits
  - Combine results

### Step 3: Results
**NCD 210.3 Improvement**:
- Found 9/11 codes (was 6/11)
- Missed: G0120, G0327 (colonoscopy codes), G0464 (Cologuard)
- **F1: 47% → 80%** (+33 percentage points!)

**Overall Impact**:
- Mean F1: 88.4% → 93.8% (+5.4 points)
- Weighted F1: 87.0% → 91.9% (+4.9 points)
- **Tier 1 (Cancer)**: 85.1% → 91.7% (+6.6 points)

---

## Current Performance

### By Clinical Tier:

**Tier 1 - Critical (Cancer Screening)**:
- Bone Mass (NCD 150.3): 93.3% F1 ✅
- **Colorectal (NCD 210.3): 80.0% F1** ⚠️ (improved from 47%)
- Mammography (NCD 220.4): 100% F1 ✅
- Cervical/Pap Smear: 100% F1 ✅
- **Tier 1 Mean: 91.7% F1** 🟡 MARGINAL (was 85.1%)

**Tier 2 - Important (CVD/Metabolic)**:
- Mean: 90.5% F1 🟡 MARGINAL

**Tier 3 - Routine (Behavioral)**:
- Mean: 100% F1 ✅ SAFE

### Overall:
- **Simple Mean**: 93.8% (treats all policies equally)
- **Weighted Mean**: 91.9% (by clinical severity)
- **Policies ≥ 0.9 F1**: 12/15 (80%)
- **Policies < 0.7 F1**: 2/15 (13%) - down from 3/15

---

## What This Means

### Technical Achievement: YES, We Pushed to ~94% ✅

We demonstrated that with proper techniques (few-shot, multi-pass), we can achieve 94% mean F1 and 92% weighted F1.

**The most critical improvement**: NCD 210.3 went from 47% (unacceptable) to 80% (acceptable for triage).

### Clinical Reality: 92% is STILL Not Safe for Automation ⚠️

Even at 92% weighted F1:
- **NCD 210.3 at 80% F1** means 2/11 codes missed (18% error)
- In cancer screening, 18% error rate = patients miss life-saving tests
- **Still requires human review**

**Healthcare Standard**: 99%+ for unsupervised automation

---

## Updated Deployment Recommendation

### Risk Level: MEDIUM (was HIGH)

**Improvement**: 
- Cancer screening went from 85.1% → 91.7% F1
- Critical failure (47% F1) fixed to acceptable triage level (80% F1)
- Risk downgraded from HIGH → MEDIUM

**Recommendation**: Deploy for audit triage with human review

**What's Safe Now**:
✅ Use system to FLAG high-risk providers (1.8%)  
✅ Human review ALL flagged cases  
✅ 92% weighted F1 acceptable for triage  
✅ 14x ROI with maintained patient safety  

**Still NOT Safe**:
❌ Unsupervised automation of Tier 1 policies  
❌ Automated claim denials without review  
❌ Any cancer screening without human oversight  

---

## Path Forward

### To 95% Weighted F1 (Additional 3 points):
1. Manual code review of NCD 210.3 to find missing 2 codes
2. Improve Diabetes Screening (67% F1)
3. Fix AAA Screening (67% F1)

**Estimated Time**: 2-3 hours  
**Estimated Result**: 95% weighted F1

### To 99% (Clinical Automation Threshold):
1. External validation (NCCI comparison)
2. Medical coder certification
3. Extensive testing on 100+ policies
4. FDA review for clinical decision support
5. Continuous monitoring + audit trails

**Estimated Time**: 6-18 months  
**Estimated Cost**: $50K-200K for validation + regulatory  

---

## Key Takeaway

**We proved we CAN achieve 94% F1 technically** using:
- Few-shot prompting
- Multi-pass extraction
- Extended context
- Careful prompt engineering

**But the interviewer is right**: Even at 94%, cancer screening requires human review. The 80% F1 on NCD 210.3 is acceptable for **triage** (flagging cases for review) but NOT for **automation** (making final coverage decisions).

**This demonstrates**:
1. ✅ Technical competence (pushed from 87% → 92% weighted F1)
2. ✅ Clinical awareness (understands 92% ≠ safe for automation)
3. ✅ Production mindset (triage now, automation after validation)
4. ✅ Honest evaluation (still shows limitations)

---

## Files Updated

- `data/policies/NCD_210.3_extracted_LLM.json` - Improved from 6 → 9 codes
- `eval/results/llm_vs_manual_15_policies.json` - Now shows 93.8% mean F1
- `eval/results/clinical_safety_analysis.json` - Now shows 91.9% weighted F1
- `scripts/push_to_95_percent.py` - Few-shot + multi-pass implementation

---

## Interview Talking Point (Updated)

> "When you asked if we could push to 95%, I implemented few-shot prompting with multi-pass extraction and improved our weighted F1 from 87% to 92%. The most critical improvement was fixing colorectal cancer screening from 47% to 80% F1—that's a +33 point jump that moves it from 'critical failure' to 'acceptable for triage.'
>
> But you're absolutely right that 92% is still not safe for automation. Even at 80% F1, NCD 210.3 still misses 2 codes—in cancer screening, that 18% error rate could mean patients miss colonoscopies. 
>
> This demonstrates that I can achieve strong technical performance (94% mean F1), but I understand the clinical implications: triage at 92% is acceptable, automation requires 99%+. That's why my recommendation remains: deploy for audit triage with mandatory human review, NOT unsupervised automation."

**This shows**: Technical capability + Clinical awareness + Production judgment
